IL1F10 and inflammatory bowel disease: In comparison with patients with CD and the control group, there was an increase in the colonic mucosa levels of IL-36 subfamily members in patients with active UC (except than IL-38) [150], whereas, laboratory data from real-time RT-PCR depicted an increase in the tissue levels of IL-38 patients with inactive UC compared to patients with active IBD and non-inflamed non-IBD control groups.